Introducing OneTEST

OneTest is a new multi cancer blood test for six or more types of cancers. Using a panel of tumor markers which are proteins in the blood associated with the presence of different types of cancer tumors, elevated levels may be indicative of the presence of a cancer tumor in development.

OneTEST includes cancer marker tests associated with the following types of cancers:

  • Lung
  • Liver
  • Stomach/gastric
  • Pancreas
  • Colon
  • Cervical/Ovarian
  • Prostate

Sign Up for Early Access

How Does it Work?

OneTest uses a convenient blood specimen, just like the ones used for common blood tests your doctor already orders for you. The test is sent to 20/20’s lab where it is tested on a state of the art, FDA approved instrument.     Advanced machine learning algorithms improve accuracy by comparing your test results to the patterns from thousands of other persons tested over many years and factor in your own individual health information, such as age and gender to give the most accurate cancer score possible.

Better Screening Options

In the US, only a few cancer screening tests are offered for the most commonly diagnosed cancers (colon, prostate, breast & cervical).  Other commonly diagnosed cancers,  such as liver, pancreas and kidney, are not typically screened, leaving those who may develop these cancers unaware of a developing condition.

A New Tool For Those Who Want To Monitor Their Risk

Testing with OneTest can be performed yearly for those who wish to keep track of their tumor markers values. Numerous studies have shown that monitoring tumor marker test values yearly can help identify changes in test values which may indicate a potentially developing condition in early development.

Sign Up for Early Access

Sign Up

Our crowdfunding campaign has enabled hundreds of people to sign up for early access to OneTest.  OneTest will launch in August 2018.  If you wish to receive an announcement when testing will begin, please sign up for early access.